CURRENT NEWS

• 07.12.2019
  Aptose Presents Highlights From Corporate Event at ASH
• 06.12.2019
  Taro Announces Resignation of Chief Financial Officer
• 06.12.2019
  LINK Medical Partners with Sedana Medical for Its International Phase III Study of Inhaled Sedation with Isoflurane and AnaConDa for Children in Intensive Care Units
• 06.12.2019
  Agilent Ranked Among Top Four Best Workplaces in Greater China and Receives Certification as a Best Workplace for Women in Greater China
• 06.12.2019
  Orgenesis and Theracell to Launch Point of Care Cell and Gene Therapy Centers Within HYGEIA Group's Hospital Network in Greece
• 06.12.2019
  Penthrox Marketing Authorisation Application in Russia
• 06.12.2019
  Variantyx Features Its Whole Genome Sequencing (WGS)-Based Epilepsy Test at American Epilepsy Society Annual Meeting
• 06.12.2019
  Canopy Growth Provides Update on 2.0 Product Rollout
• 06.12.2019
  Gilero Opens New Design Center in Southern California
• 06.12.2019
  Alector Announces Phase 1 Data on AL002 at the 12th Clinical Trials on Alzheimer's Disease (CTAD) Meeting
• 06.12.2019
  Medtronic Canada Recognized as One of Greater Toronto's Top Employers for 2020
• 06.12.2019
  Enteris BioPharma's Licensing Partner, Cara Therapeutics, Announces Top Line Data From Phase 2 Trial of Peptelligence-Engineered Oral KORSUVA for the Treatment of Pruritus in Patients With Advanced Chronic Kidney Disease (CKD)
• 06.12.2019
  Biohaven's Troriluzole Successfully Advances Past Interim Futility Analysis in Pivotal Phase 2/3 Alzheimer's Disease Study
• 06.12.2019
  IntelGenx Announces Issuance of Shares in Payment of Interest on Outstanding Debentures
• 06.12.2019
  Dr. Reddy's Laboratories Announces the Launch of Deferasirox Tablets for Oral Suspension, in the U.S. Market
• 06.12.2019
  Rocket Pharmaceuticals Announces First Patient Treated in Global Registrational Phase 2 Study of RP-L102 “Process B” for Fanconi Anemia
• 06.12.2019
  CENTOGENE Expands Executive Leadership Team
• 06.12.2019
  Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 2020
• 06.12.2019
  Dr. Reddy's Laboratories Announces the Launch of Deferasirox Film-Coated Tablets, in the U.S. Market
• 05.12.2019
  Q2 Interim Report: Work with the FDA Application Progressing as Planned

Records per page:

Page

Total: 15033 records.